STILL SEEKING OUTCOMES AFTER 6TH STOMA APPLIANCE SCHEME SCHEDULE REVIEW:
LOWER QUALITY OF LIFE AND OTHER HEALTH IMPACTS EXPERIENCED BY OSTOMATES
Matt Dalton
Chair, Stoma Industry Association
SEGMENT RELEASE
Filmed in Sydney, New South Wales | December 2024
A stoma is a surgically created opening in the abdomen to remove body waste, such as faeces and urine. Many conditions can require a stoma, including colorectal cancer, inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, bladder cancer, injury trauma, and congenital defects.
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
The report found that the Quality of Life (QoL) for Australian ostomates is lower than other developed nations and the general community. The reason for this includes:
- Australia reimburses fewer products on the Stoma Appliance Scheme (SAS). The UK provides 60 per cent more, for example.
- Australian spending as a percentage of GDP is five times smaller than Canada, and three times smaller than the UK.
- There are fewer specialist nurses to support the patient population. According to the Australian Association of Stomal Therapy Nurses, “A Stomal Therapy Nurse (STN) specialises in the management of patients with faecal and urinary diversions. In addition, the STN is an expert in the management of difficult and draining wounds, fistulae, gastrostomies, acute and chronic wounds and associated skin care. In short, STNs can assist with advice and management of any stoma and wound issue, and may also provide continence advice.”
The report also details the daily challenges of Australian ostomates:
- 1 in 5 stoma patients isolate themselves from others
- 65 per cent of patients say their ability to work is negatively impacted
- 3 in 5 patients experience a reduction in intimacy
Stoma appliances and supporting products are subsidised by the Commonwealth funded scheme.
There have been five reviews of the SAS, none of which have been released. The current (sixth) review released earlier this year by the Australian Government.
Australian Health Journal spoke with the Stoma Industry Association Chair, Matt Dalton about the same access to products needed by 50,000 Australian ostomates and the quality of life as patients overseas.
You Might also like
-
Building capacity with job-ready clinical trial interns
The Victorian Comprehensive Cancer Centre Alliance, or VCCC Alliance for short, is a Victorian partnership of 10 research, academic and clinical institutions looking at improving cancer outcomes for patients.
The VCCC Alliance SKILLED clinical trial internships program is a pathway for scientists to build role-specific clinical trial knowledge, experience and in a clinical trials unit through theoretical and on-the-job training. The internship program is a 40 week intensive program to get science student interns job ready for clinical trial assistant and study coordinator internship roles.
-
A 40-Year Journey: Insights from Tasmania’s Chief Nurse & Midwife
Reflecting on her nursing journey on the Tasmanian Health website on International Nurses Day 2025, Chief Nurse and Midwife, Francine Douce, has seen plenty of change since the start of her nursing and midwifery career, 42 years ago.
-
Recognising clinical trials and the people behind the research
Australia’s clinical trials community came together to celebrate outstanding research and recognise the people and teams making a meaningful difference to healthcare at the 2026 ACTA Trial of the Year Awards.
Now in its 10th year, the awards continue to shine a light on investigator-led clinical trials and initiatives that are improving clinical practice, influencing healthcare policy and delivering better outcomes for patients across Australia and beyond.